Full Text
PMS53 UTILISATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN QUEBEC, CANADA- IS THERE A CHANGE IN THE PATIENT RISK PROFILE AFTER THE WITHDRAWAL OF ROFECOXIB?

Abstract

Authors

E Rahme JP Roussy JP Lafrance H Nedjar S Morin

Back to Volume 13, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×